The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man
Clinical trial NCT04816123 · COMPLETED
Trial details
- NCT number
- NCT04816123
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2018-12-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.